LB PHARMACEUTICALS INC (LBRX): Institutional Ownership
Hedge funds and institutional managers reporting a position in LBRX. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
7
13F filers
Aggregate Value
$37.1M
Across holders
Last Price
$31.92
2026-06-26
Sector
—
GICS
Holder activity4 new1 added1 reduced
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| BALYASNY ASSET MANAGEMENT LLC CIK 0001218710 | Hedge Fund | 924K | $22.8M | 61.5% | 0.0% | Added | +$663K | Q1 2026 |
| CITADEL ADVISORS LLC CIK 0001423053 | Hedge Fund | 406K | $10.0M | 27.0% | 0.0% | Reduced | $-48K | Q1 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. CIK 0001165408 | Hedge Fund | 200K | $3.2M | 8.5% | 0.0% | New | — | Q3 2025 |
| MARSHALL WACE, LLP CIK 0001318757 | Hedge Fund | 14K | $319K | 0.9% | 0.0% | New | — | Q4 2025 |
| TWO SIGMA INVESTMENTS, LP CIK 0001179392 | Hedge Fund | 13K | $314K | 0.8% | 0.0% | Unchanged | +$0 | Q1 2026 |
| Hudson Bay Capital Management LP CIK 0001393825 | Hedge Fund | 18K | $276K | 0.7% | 0.0% | New | — | Q3 2025 |
| Brevan Howard Capital Management LP CIK 0001512857 | Hedge Fund | 13K | $209K | 0.6% | 0.0% | New | — | Q3 2025 |
Added
Hedge Fund
$22.8M· 61.5% of total· 0.0% port· 924K sh· +$663K QoQ· Q1 2026
Reduced
Hedge Fund
$10.0M· 27.0% of total· 0.0% port· 406K sh· $-48K QoQ· Q1 2026
New
Hedge Fund
$3.2M· 8.5% of total· 0.0% port· 200K sh· — QoQ· Q3 2025
New
Hedge Fund
$319K· 0.9% of total· 0.0% port· 14K sh· — QoQ· Q4 2025
Unchanged
Hedge Fund
$314K· 0.8% of total· 0.0% port· 13K sh· +$0 QoQ· Q1 2026
New
Hedge Fund
$276K· 0.7% of total· 0.0% port· 18K sh· — QoQ· Q3 2025
New
Hedge Fund
$209K· 0.6% of total· 0.0% port· 13K sh· — QoQ· Q3 2025